台灣泌尿科醫學會E-School

台灣泌尿科醫學會E-School

MP01-05: The prognostic utility of FBLN2 expression in patients with urothelial carcinoma

2021-05-24 • 觀看: 1532 • 回應: 0 • doc
MP01-04: Optimizing the biopsy strategy of MRI/US fusion transperineal prostate biopsy: saturation target biopsy

2021-05-24 • 觀看: 1681 • 回應: 0 • doc
MP01-03: Transperineal ultrasound magnetic resonance imaging fusion biopsy combined transrectal ultrasound systemic biopsy for prostate cancer detection – A single center experience

2021-05-24 • 觀看: 1705 • 回應: 0 • doc
MP01-02: The efficacy of the adjustable male sling system for stress urinary incontinence after radical prostatectomy

2021-05-24 • 觀看: 1937 • 回應: 0 • doc
MP01-01: The risk factors analysis for the biochemical failure within two years for patients with PSA failure after robotic radical prostatectomy

2021-05-24 • 觀看: 1577 • 回應: 0 • doc
PD08-6: Immune checkpoint biomarker on circulating tumor cells as a potential predictor of therapeutic efficacy in urothelial carcinoma patients

2021-05-24 • 觀看: 1315 • 回應: 0 • doc
PD08-5: miR-375 suppresses upper tract urothelial carcinoma cell migration and invasion via targeting Derlin-1

2021-05-24 • 觀看: 1231 • 回應: 0 • doc
PD08-4: Partial cystectomy after neoadjuvant chemotherapy for muscle invasive bladder cancer

2021-05-24 • 觀看: 1674 • 回應: 0 • doc
PD08-3: Long non-coding RNA mediates cisplatin and gemcitabine resistance in upper tract urothelial carcinoma cells by sponging of miR-31

2021-05-24 • 觀看: 1344 • 回應: 0 • doc
PD08-2: Treatment outcome and FGFR alteration rate in unresectable locally advanced or metastatic urothelial cancer in Taiwan

2021-05-24 • 觀看: 1726 • 回應: 0 • doc
PD08-1: Can ERBT take place of the importance of traditional TURBt?

2021-05-24 • 觀看: 2002 • 回應: 0 • doc
PD07-6: Experience with modified Makuuchi incision in the surgical treatment for huge retroperitoneal tumor

2021-05-20 • 觀看: 1694 • 回應: 0 • doc

Prev
562
563
564
565
566
567
568
569
570
571
Next
/ 1134